Evidence map›Paper›PMID 17088351›Full record

ArticleInfection and immunity2007

Immunogenic and protective potential of mutans streptococcal glucosyltransferase peptide constructs selected by major histocompatibility complex class II allele binding.

S Culshaw, K Larosa, H Tolani, X Han, J W Eastcott, D J Smith, M A Taubman

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

S CulshawDepartment of Immunology, The Forsyth Institute, 140 The Fenway, Boston, MA 02115-3799, USA.
K Larosa
H Tolani
X Han
J W Eastcott
D J Smith
M A Taubman
Fenway Health · US

Funding

REGULATORY CELLS IN EXPERIMENTAL PERIODONTAL DISEASER01DE003420 · NIDCR · FORSYTH INSTITUTE · PI KAWAI, TOSHIHISA · 1985 to 2012
$4.3M
SYNTHETIC PEPTIDE VACCINES FOR DENTAL CARIESR01DE004733 · NIDCR · FORSYTH INSTITUTE · PI TAUBMAN, MARTIN A · 1985 to 2005
$3.0M
Passive Immunotherapy for Pediatric Mutans Streptococcal InfectionsR56DE004733 · NIDCR · ADA FORSYTH INSTITUTE, INC. · PI TAUBMAN, MARTIN A · 2007 to 2009
$2.1M
NIDCR NIH HHS DE-04733NIDCR NIH HHS L30 DE020037NIDCR NIH HHS R01 DE003420NIDCR NIH HHS R01 DE004733NIDCR NIH HHS R56 DE004733
6 · The paper itself

Abstract

Mutans streptococcal glucosyltransferases (GTF) have been demonstrated to be effective components of dental caries vaccines. We had previously selected peptide subunits of GTF for vaccine development based on putative functional significance and conservation of GTF primary structure among enzyme isoforms. In this study, 20 20-mer linear GTF peptides were synthesized, 17 identified on the basis of the highest potential major histocompatibility complex (MHC) class II-binding activity using computer-generated algorithms (Epimatrix and ProPred) and 3 with previously demonstrated functional significance. The immunoreactivities of these peptides were explored with rodent systems. Sera from GTF-immunized rats, assessed for binding to linear peptides by enzyme-linked immunosorbent assay, demonstrated immunoglobulin G antibody reactivity with peptides 6 and 11 and a T-cell proliferation response to peptides 6, 9, 11, and 16. Multiple antigenic peptide (MAP) constructs were synthesized from promising linear sequences. Rats that were immunized with MAP 7, 11, or 16, respectively, responded well to the immunizing MAP. Most importantly, a robust immune response (antibody and T-cell proliferation) was observed to native GTF following MAP 11 (amino acids 847 to 866; VVINNDKFVSWGITDFEM) immunization. This response inhibited GTF enzyme function. Two dental caries pathogenesis experiments were performed wherein rats were immunized with MAP constructs 11, 16, and/or 11 plus 16, followed by infection with cariogenic Streptococcus sobrinus. In both experiments cariogenic bacterial recoveries were reduced relative to total streptococci in the MAP 11- and MAP 11 plus 16-immunized groups, and the extent of dental caries was also significantly reduced in these groups. Thus, we have identified a peptide with projected avid MHC-binding activity that elicited immunoreactivity with native GTF and demonstrated protection against dental caries infection after immunization, implying that this peptide may be important in a subunit dental caries vaccine.

Indexed as

AnimalsAntibodies, BacterialCell ProliferationColony Count, MicrobialComputational BiologyDisease Models, AnimalEnzyme-Linked Immunosorbent AssayGlucosyltransferasesHistocompatibility Antigens Class IIImmunoglobulin GLymphocytesMouthMutationPeptidesRatsRats, Sprague-DawleyAntibodies, BacterialGlucosyltransferasesHistocompatibility Antigens Class IIImmunoglobulin GPeptidesVaccines, Subunit

Identifiers

PMID17088351
PMCPMC1828508
OpenAlexW2169894393

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.